Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 1
1980 1
1981 1
1983 1
1984 2
1985 1
1986 2
1987 3
1988 2
1989 3
1990 3
1991 3
1992 8
1993 15
1994 14
1995 7
1996 13
1997 8
1998 17
1999 13
2000 16
2001 20
2002 16
2003 18
2004 18
2005 23
2006 44
2007 30
2008 45
2009 28
2010 32
2011 35
2012 24
2013 18
2014 18
2015 25
2016 21
2017 23
2018 30
2019 40
2020 42
2021 26
2022 15
2023 14
2024 18
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

671 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Atypical hyperplasia of breast"
Page 1
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z. Elfgen C, et al. Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17. Virchows Arch. 2023. PMID: 37330436 Free PMC article. Review.
The heterogeneous group of B3 lesions in the breast harbors lesions with different malignant potential and progression risk. As several studies about B3 lesions have been published since the last Consensus in 2018, the 3rd International Consensus Conference discussed the s …
The heterogeneous group of B3 lesions in the breast harbors lesions with different malignant potential and progression risk. As sever …
Reassessing risk models for atypical hyperplasia: age may not matter.
Mazzola E, Coopey SB, Griffin M, Polubriaginof F, Buckley JM, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi A, Hughes KS. Mazzola E, et al. Breast Cancer Res Treat. 2017 Sep;165(2):285-291. doi: 10.1007/s10549-017-4320-7. Epub 2017 Jun 6. Breast Cancer Res Treat. 2017. PMID: 28589368 Free PMC article. Review.
PURPOSE: The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia ("atypia", ductal [ADH], lobular [ALH], or severe ADH) on the risk of developing subsequent invasive breast cancer or ductal carcinoma in situ (DCIS). …
PURPOSE: The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia ("atypia", ductal …
Inter-observer agreement in the diagnosis of breast atypical ductal hyperplasia: A systematic review.
González Mariño MA. González Mariño MA. Breast Dis. 2022;41(1):545-550. doi: 10.3233/BD-220029. Breast Dis. 2022. PMID: 36683493 Free article.
OBJECTIVE: To review the concordance between pathologists in the diagnosis of atypical ductal hyperplasia of the breast. METHODS: Systematic review of articles registered in the PubMed database with the terms "pathologists" and "atypical ductal hype …
OBJECTIVE: To review the concordance between pathologists in the diagnosis of atypical ductal hyperplasia of the breast …
Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.
Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Dyrstad SW, et al. Breast Cancer Res Treat. 2015 Feb;149(3):569-75. doi: 10.1007/s10549-014-3254-6. Epub 2015 Jan 31. Breast Cancer Res Treat. 2015. PMID: 25636589 Review.
English retrospective and prospective observational studies published from 1972 to 2010 evaluating BBD and the risk of breast cancer were included with data acquisition reported from 1930 to 2007. ...The most commonly reported pathologies were decided prior to extra …
English retrospective and prospective observational studies published from 1972 to 2010 evaluating BBD and the risk of breast …
B3 lesions of the breast and cancer risk. A single-centre experience.
Marino G, Accardo G, Thodas A, Botte M, Di Nardo G, Calice G, Patitucci G, Di Cerbo A, La Torre G. Marino G, et al. Ann Ital Chir. 2023;94:226-230. Ann Ital Chir. 2023. PMID: 37530037
METHODS: Between January 2018 and December 2021, 83 patients undergoing ultrasound guided tru-cut needle biopsy or VABB with a B3 diagnosis and surgical excision following multidisciplinary discussion were retrospectively reviewed in our Breast Unit. RESULTS: Out of a tota …
METHODS: Between January 2018 and December 2021, 83 patients undergoing ultrasound guided tru-cut needle biopsy or VABB with a B3 diagnosis …
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
Laws A, Leonard S, Hershey E, Stokes S, Vincuilla J, Sharma E, Milliron K, Garber JE, Merajver SD, King TA, Pilewskie ML. Laws A, et al. Ann Surg Oncol. 2024 May;31(5):3120-3127. doi: 10.1245/s10434-024-14947-0. Epub 2024 Jan 23. Ann Surg Oncol. 2024. PMID: 38261128
BACKGROUND: High-risk lesions (HRL) of the breast are risk factors for future breast cancer development and may be associated with a concurrent underlying malignancy when identified on needle biopsy; however, there are few data evaluating HRLs in carriers of germlin …
BACKGROUND: High-risk lesions (HRL) of the breast are risk factors for future breast cancer development and may be associated …
Role of breast MRI in predicting histologic upgrade risks in high-risk breast lesions: A review.
Li X, Sun K, Chai W, Zhu H, Yan F. Li X, et al. Eur J Radiol. 2021 Sep;142:109855. doi: 10.1016/j.ejrad.2021.109855. Epub 2021 Jul 9. Eur J Radiol. 2021. PMID: 34303150 Review.
RESULTS AND CONCLUSIONS: In terms of management options, Atypical ductal hyperplasia (ADH) and Lobular neoplasia (LN) (the top two high-risk lesions with the highest upgrade rate and frequency) were treated with surgical resection. ...At the same time, Dynamic contr …
RESULTS AND CONCLUSIONS: In terms of management options, Atypical ductal hyperplasia (ADH) and Lobular neoplasia (LN) (the top …
Effective Surveillance of High-Risk Women.
Lotz M, Ghebremichael M, Chervinsky K, Zorc T, Brenner C, Bousvaros G, Pories SE. Lotz M, et al. Clin Breast Cancer. 2022 Apr;22(3):e263-e269. doi: 10.1016/j.clbc.2021.07.014. Epub 2021 Jul 27. Clin Breast Cancer. 2022. PMID: 34429241
BACKGROUND: This study addresses the effectiveness of risk models and screening breast magnetic resonance imaging (MRI) in women who have atypical hyperplasia (AH), lobular carcinoma in situ (LCIS), or a family history of breast cancer, but not a genet …
BACKGROUND: This study addresses the effectiveness of risk models and screening breast magnetic resonance imaging (MRI) in women who …
Upgrade Rate of Atypical Ductal Hyperplasia: Ten Years Experience and Predictive Factors.
Gagnon N, Martel E, Cadrin-Chênevert A, Ledoux E, Racicot C, Villiard R. Gagnon N, et al. J Surg Res. 2021 Oct;266:311-318. doi: 10.1016/j.jss.2021.03.063. Epub 2021 May 25. J Surg Res. 2021. PMID: 34044175
BACKGROUND: Atypical ductal hyperplasia (ADH) is a benign epithelial proliferative lesion with histologic features resembling those seen in low grade ductal carcinoma in situ (DCIS). ...The objective of this study was to determine the upgrade rate from ADH on stereo …
BACKGROUND: Atypical ductal hyperplasia (ADH) is a benign epithelial proliferative lesion with histologic features resembling …
671 results